D
David A. Cooper
Researcher at Pfizer
Publications - 965
Citations - 81765
David A. Cooper is an academic researcher from Pfizer. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 117, co-authored 903 publications receiving 69249 citations. Previous affiliations of David A. Cooper include Boston Children's Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Results of the British Association of Urological Surgeons female stress urinary incontinence procedures outcomes audit 2014-2017.
Sophia Cashman,Suzanne Biers,Tamsin Greenwell,Christopher Harding,Roland Morley,David A. Cooper,Sarah Fowler,Nikesh Thiruchelvam,Urodynamic Urology +8 more
TL;DR: To analyse the results of the stress urinary incontinence (SUI) audit conducted by the British Association of Urological Surgeons (BAUS), and to present UK urologists’ contemporary management of SUI.
Journal ArticleDOI
Adherence and Risk Behaviour in Patients with HIV Infection Receiving Antiretroviral Therapy in Bangkok
Amanda Clarke,Stephen J. Kerr,Adam Honeybrook,David A. Cooper,Anchalee Avihingsanon,Chris Duncombe,Praphan Phanuphak,Kiat Ruxrungtham,Jintanat Ananworanich,John M. Kaldor +9 more
TL;DR: Level of USR in this resource limited setting were reassuringly low and not associated with poor ART adherence; as all USR patients had undetectable viral loads onward HIV transmission risk is likely to be low but not negligible; Nonetheless condom negotiation techniques, particularly in women, may be useful in this group.
Journal ArticleDOI
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme
Nila J. Dharan,Tomas Radovich,Samuel Che,Kathy Petoumenos,Prabhjot Juneja,Matthew Law,Robin Huang,Hamish McManus,Mark N. Polizzotto,Rebecca Guy,Peter Cronin,David A. Cooper,Richard Gray +12 more
TL;DR: While most patients purchased optimal ART regimens with low potential for significant drug interactions, regimen choices in the setting of risk factors for heart disease, renal disease and low bone mineral density appeared suboptimal.
Journal ArticleDOI
Observing patients after antibiotics are discontinued.
Bruce F. Farber,David A. Cooper +1 more
TL;DR: To the Editor: Of the more than 40 million patients hospitalized in the United States yearly, approximately 2 million acquire nosocomial infections and patients with infections frequently remain in hospital for at least a year after diagnosis.
Journal ArticleDOI
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol
Jane E. Norman,John Norrie,Graeme MacLennan,David A. Cooper,Sonia Whyte,Sarah Cunningham Burley,Joel Smith,Andrew Shennan,Stephen C. Robson,Steven Thornton,Mark D. Kilby,Neil Marlow,Sarah J. Stock,Philip R Bennett,Jane Denton +14 more
TL;DR: The STOPPIT-2 study will resolve uncertainty around effectiveness for women with a twin pregnancy and a cervical length of 35 mm or less, define adverse effects, ascertain acceptability and estimate National Health Service costs and savings.